ERIC W. FANGMANN

Corporate Board Profile

Tech Score: 0/100

Capstone Holding Corp.

Filing Date	Source Excerpt
2014-05-02	Eric W. Fangmann Mr. Fangmann, age 44, has been the Chief Financial Officer for Lloyd I. Miller, III, since June 2011. Mr. Fangmann is also the Acting President and Acting Chief Financial Officer for Pharmos Corporation, a pharmaceutical company, since 2012. Mr. Fangmann was introduced and recommended to the Board as a nominee for director by Lloyd I. Miller, III, a significant shareholder. The Board believes Mr. Fangmann’s diverse financial experience brings important experience to the Board and qualifies him to serve on our Board.
2015-05-08	Eric W. Fangmann, age 45, has served as a director of the Company since June 2014. The Audit Committee met five times in 2014 and consists of Mr. Howse (Chairman) and Mr. Fangmann. The following table sets forth compensation awarded to the Company’s directors during the last fiscal year. Eric W. Fangmann received total compensation of $20,000.

Filing Date

Source Excerpt

2014-05-02

Eric W. Fangmann Mr. Fangmann, age 44, has been the Chief Financial Officer for Lloyd I. Miller, III, since June 2011. Mr. Fangmann is also the Acting President and Acting Chief Financial Officer for Pharmos Corporation, a pharmaceutical company, since 2012. Mr. Fangmann was introduced and recommended to the Board as a nominee for director by Lloyd I. Miller, III, a significant shareholder. The Board believes Mr. Fangmann’s diverse financial experience brings important experience to the Board and qualifies him to serve on our Board.

2015-05-08

Eric W. Fangmann, age 45, has served as a director of the Company since June 2014. The Audit Committee met five times in 2014 and consists of Mr. Howse (Chairman) and Mr. Fangmann. The following table sets forth compensation awarded to the Company’s directors during the last fiscal year. Eric W. Fangmann received total compensation of $20,000.

Data sourced from SEC filings. Last updated: 2026-02-03